|
1
|
Urayama S: Pancreatic cancer early
detection: Expanding higher-risk group with clinical and
metabolomics parameters. World J Gastroenterol. 21:17072015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gräntzdörffer I, Carl-McGrath S, Ebert MP
and Röcken C: Proteomics of pancreatic cancer. Pancreas.
36:329–336. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Desmetz C, Mange A, Maudelonde T and
Solassol J: Autoantibody signatures: Progress and perspectives for
early cancer detection. J Cell Mol Med. 15:2013–2024. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Caron M, Choquet-Kastylevsky G and
Joubert-Caron R: Cancer immunomics using autoantibody signatures
for biomarker discovery. Mol Cell Proteomics. 6:1115–1122. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dudas SP, Chatterjee M and Tainsky MA:
Usage of cancer associated autoantibodies in the detection of
disease. Cancer Biomark. 6:257–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mojtahedi Z, Safaei A, Yousefi Z and
Ghaderi A: Immunoproteomics of HER2-positive and HER2-negative
breast cancer patients with positive lymph nodes. OMICS.
15:409–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xia Q, Kong XT, Zhang GA, Hou XJ, Qiang H
and Zhong RQ: Proteomics-based identification of DEAD-box protein
48 as a novel autoantigen, a prospective serum marker for
pancreatic cancer. Biochem Biophys Res Commun. 330:526–532. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hong SH, Misek DE, Wang H, Puravs E,
Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD and
Hanash SM: An autoantibody-mediated immune response to calreticulin
isoforms in pancreatic cancer. Cancer Res. 64:5504–5510. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tomaino B, Cappello P, Capello M,
Fredolini C, Ponzetto A, Novarino A, Ciuffreda L, Bertetto O, De
Angelis C, Gaia E, et al: Autoantibody signature in human ductal
pancreatic adenocarcinoma. J Proteome Res. 6:4025–4031. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Principe M, Ceruti P, Shih NY,
Chattaragada MS, Rolla S, Conti L, Bestagno M, Zentilin L, Yang SH,
Migliorini P, et al: Targeting of surface alpha-enolase inhibits
the invasiveness of pancreatic cancer cells. Oncotarget.
6:110982015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elsässer HP, Lehr U, Agricola B and Kern
HF: Structural analysis of a new highly metastatic cell line PaTu
8902 from a primary human pancreatic adenocarcinoma. Virchows Arch
B Cell Pathol Incl Mol Pathol. 64:201–207. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rezaei M, Hosseini A, Nikeghbalian S and
Ghaderi A: Establishment and characterization of a new human acinar
cell carcinoma cell line, faraz-ICR, from pancreas. Pancreatology.
17:303–309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okutucu B, Dınçer A, Habib Ö and Zıhnıoglu
F: Comparison of five methods for determination of total plasma
protein concentration. J Biochem Biophys Methods. 70:709–711. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Casiano CA, Mediavilla-Varela M and Tan
EM: Tumor-associated antigen arrays for the serological diagnosis
of cancer. Mol Cell Proteomics. 5:1745–1759. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dumstrei K, Chen H and Brenner H: A
systematic review of serum autoantibodies as biomarkers for
pancreatic cancer detection. Oncotarget. 7:111512016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan S, Brentnall TA and Chen R:
Glycoproteins and glycoproteomics in pancreatic cancer. World J
Gastroenterol. 22:9288–9299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J, Wang LJ, Ying X, Han SX, Bai E,
Zhang Y and Zhu Q: Immunodiagnostic value of combined detection of
autoantibodies to tumor-associated antigens as biomarkers in
pancreatic cancer. Scand J Immunol. 75:342–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Durbeej M: Laminins. Cell Tissue Res.
339:259–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kikkawa Y, Sanzen N and Sekiguchi K:
Isolation and characterization of laminin-10/11 secreted by human
lung carcinoma cells laminin-10/11 mediates cell adhesion through
integrin alpha3 beta1. J Biol Chem. 273:15854–15859. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Connolly D, Abdesselam I, Verdier-Pinard P
and Montagna C: Septin roles in tumorigenesis. Biol Chem.
392:725–738. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Parker AL, Kavallaris M and McCarroll JA:
Microtubules and their role in cellular stress in cancer. Front
Oncol. 4:1532014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee KM, Cao D, Itami A, Pour PM, Hruban
RH, Maitra A and Ouellette MM: Class III beta-tubulin, a marker of
resistance to paclitaxel, is overexpressed in pancreatic ductal
adenocarcinoma and intraepithelial neoplasia. Histopathology.
51:539–546. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang D, Jin N, Sun W, Li X, Liu B, Xie Z,
Qu J, Xu J, Yang X, Su Y, et al: Phosphoglycerate mutase 1 promotes
cancer cell migration independent of its metabolic activity.
Oncogene. 36:2900–2909. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Colell A, Green DR and Ricci JE: Novel
roles for GAPDH in cell death and carcinogenesis. Cell Death
Differ. 16:1573–1581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo C, Liu S and Sun MZ: Novel insight
into the role of GAPDH playing in tumor. Clin Transl Oncol.
15:167–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giusti L, Iacconi P, Ciregia F,
Giannaccini G, Donatini GL, Basolo F, Miccoli P, Pinchera A and
Lucacchini A: Fine-needle aspiration of thyroid nodules: Proteomic
analysis to identify cancer biomarkers. J Proteome Res.
7:4079–4088. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu ZJ, Song QF, Jiang SS, Song Q, Wang W,
Zhang GH, Kan B, Chen LJ, Yang JL, Luo F, et al: Identification of
ATP synthase beta subunit (ATPB) on the cell surface as a non-small
cell lung cancer (NSCLC) associated antigen. BMC Cancer. 9:162009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Borrelli A, Schiattarella A, Bonelli P,
Tuccillo FM, Buonaguro FM and Mancini A: The functional role of
MnSOD as a biomarker of human diseases and therapeutic potential of
a new isoform of a human recombinant MnSOD. Biomed Res Int.
2014:4767892014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weydert C, Roling B, Liu J, Hinkhouse MM,
Ritchie JM, Oberley LW and Cullen JJ: Suppression of the malignant
phenotype in human pancreatic cancer cells by the overexpression of
manganese superoxide dismutase. Mol Cancer Ther. 2:361–369.
2003.PubMed/NCBI
|
|
30
|
Liou GY and Storz P: Reactive oxygen
species in cancer. Free Radic Res. 44:479–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fujita A, Shida A, Fujioka S, Kurihara H,
Okamoto T and Yanaga K: Clinical significance of Rho GDP
dissociation inhibitor 2 in colorectal carcinoma. Int J Clin Oncol.
17:137–142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Niu H, Wu B, Jiang H, Li H, Zhang Y, Peng
Y and He P: Mechanisms of RhoGDI2 mediated lung cancer
epithelial-mesenchymal transition suppression. Cell Physiol
Biochem. 34:2007–2016. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Halder SK, Anumanthan G, Maddula R, Mann
J, Chytil A, Gonzalez AL, Washington MK, Moses HL, Beauchamp RD and
Datta PK: Oncogenic function of a novel WD-domain protein, STRAP,
in human carcinogenesis. Cancer Res. 66:6156–6166. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang X, Sun Q, Li H, Li K and Ren X: The
role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and
its potential therapeutic implications. Int J Cancer.
135:1991–1996. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhong N, Cui Y, Zhou X, Li T and Han J:
Identification of prohibitin 1 as a potential prognostic biomarker
in human pancreatic carcinoma using modified aqueous two-phase
partition system combined with 2D-MALDI-TOF-TOF-MS/MS. Tumor Biol.
36:1221–1231. 2015. View Article : Google Scholar
|
|
36
|
Leal MF, Cirilo PD, Mazzotti TK, Calcagno
DQ, Wisnieski F, Demachki S, Martinez MC, Assumpção PP, Chammas R,
Burbano RR and Smith MC: Prohibitin expression deregulation in
gastric cancer is associated with the 3′ untranslated region 1630
C> T polymorphism and copy number variation. PloS One.
9:e985832014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tung JJ and Kitajewski J: Chloride
intracellular channel 1 functions in endothelial cell growth and
migration. J Angiogenes Res. 2:232010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu J, Dong Q, Zhang B, Wang X, Ye B, Zhang
F, Song X, Gao G, Mu J, Wang Z, et al: Chloride intracellular
channel 1 (CLIC1) is activated and functions as an oncogene in
pancreatic cancer. Med Oncol. 32:1–9. 2015. View Article : Google Scholar
|
|
39
|
Al-Maghrebi M, Anim JT and Olalu AA:
Up-regulation of eukaryotic elongation factor-1 subunits in breast
carcinoma. Anticancer Res. 25:2573–2577. 2005.PubMed/NCBI
|
|
40
|
Shi H, Hayes M, Kirana C, Miller R,
Keating J, Macartney-Coxson D and Stubbs R: TUFM is a potential new
prognostic indicator for colorectal carcinoma. Pathology.
44:506–512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu C, Wang J, Li J and Fang R: Expression
of elongation factor (EF)-Tu is correlated with prognosis of
gastric adenocarcinomas. Int J Mol Sci. 12:6645–6655. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pan J, Sun LC, Tao YF, Zhou Z, Du XL, Peng
L, Feng X, Wang J, Li YP, Liu L, et al: ATP synthase
ecto-α-subunit: A novel therapeutic target for breast cancer. J
Transl Med. 9:2112011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tapper J, Kettunen E, Seppälä M, Andersson
LC and Knuutila S: Changes in gene expression during progression of
ovarian carcinoma. Cancer Genet Cytogenet. 128:1–6. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cho HJ, Baek KE, Park SM, Kim IK, Choi YL,
Cho HJ, Nam IK, Hwang EM, Park JY, Han JY, et al: RhoGDI2
expression is associated with tumor growth and malignant
progression of gastric cancer. Clin Cancer Res. 15:2612–2619. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yoneyama K, Kojima S, Kodani Y, Yamaguchi
N, Igarashi A, Kurose K, Kawase R, Takeshita T, Hattori S and
Nagata K: Proteomic identification of autoantibodies in sera from
patients with ovarian cancer as possible diagnostic biomarkers.
Anticancer Res. 35:881–889. 2015.PubMed/NCBI
|
|
46
|
Cui JW, Li WH, Wang J, Li AL, Li HY, Wang
HX, He K, Li W, Kang LH, Yu M, et al: Proteomics-based
identification of human acute leukemia antigens that induce humoral
immune response. Mol Cell Proteomics. 4:1718–1724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yan-Sanders Y, Hammons GJ and Lyn-Cook BD:
Increased expression of heterogeneous nuclear ribonucleoprotein
A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic
tumor cells. Cancer Lett. 183:215–220. 2002. View Article : Google Scholar : PubMed/NCBI
|
